HNRNPA2B1 and liver cancer: In liver cancer, by degrading HNRNPA2B1 via ubiquitination, which reduces the stability of p52 and p65 mRNAs, and inhibiting the NF-κB signaling pathway in hepatocellular carcinoma cells, lncRNA miR503HG inhibits tumor metastasis [48].